Paeds Vivas · respiratory-sleep-and-airway
Community-acquired pneumonia — branching viva
Branching viva on grading childhood pneumonia severity, justifying oral amoxicillin and restrained imaging, choosing the route of therapy, recognising atypical pneumonia and empyema, and escalating oxygen and support for severe disease.
On this page
Study tools
Target exams
Opening
Examiner: A 3-year-old arrives with three days of fever and cough, now breathing fast at 44 per minute with focal right basal crackles, mild recession, feeding three-quarters of normal and saturating 96 percent. How do you approach her? [1]
Candidate: I would make a clinical diagnosis of community-acquired pneumonia — a febrile child with fast breathing for age and focal chest signs — and grade its severity by observation before disturbing her. She has a raised respiratory rate but is alert, feeding adequately and saturating well with only mild recession, which places her in the non-severe band. My plan is oral amoxicillin at home with antipyresis and safety-net advice, and I would deliberately not order routine imaging or bloods. [1] [2]
Branch 1 — investigation and first-line therapy
Examiner: Would you get a chest X-ray to confirm it? [3]
Candidate: No, not in non-severe pneumonia. A chest radiograph does not change management in a well child treated as an outpatient, and a randomised trial in ambulatory children with acute lower respiratory infection showed imaging did not improve clinical outcome. It also cannot reliably separate bacterial from viral pneumonia. I reserve a film for severe, complicated, uncertain, recurrent or non-responding cases or a suspected effusion. [3] [2]
Examiner (probe): What antibiotic, route and duration would you choose, and why? [4]
Candidate: I would give oral amoxicillin as first-line, because it covers the pneumococcus, which is the main treatable cause, and oral therapy is as effective as intravenous therapy for a child well enough to absorb it. I would use a short course, because the SAFER trial showed about five days is non-inferior to a longer course for non-severe pneumonia, which reduces antibiotic exposure without harming outcomes. [4] [1]
References5ShowHide
- [1]Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America Clin Infect Dis, 2011.PMID 21880587
- [2]Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011 Thorax, 2011.PMID 21903691
- [3]Swingler GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children Lancet, 1998.PMID 9482294
- [4]Pernica JM, Harman S, Kam AJ, et al. Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial JAMA Pediatr, 2021.PMID 33683325
- [5]Long AM, Smith-Williams J, Mayell S, et al. 'Less may be best'-Pediatric parapneumonic effusion and empyema management: Lessons from a UK center J Pediatr Surg, 2016.PMID 26382287